Legal Representation
Attorney
Mainak H. Mehta
USPTO Deadlines
Next Deadline
3481 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2015-05-19)
Due Date
May 19, 2035
Grace Period Ends
November 19, 2035
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 9, 2025 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Sep 9, 2025 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Sep 9, 2025 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Sep 9, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| May 9, 2025 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| May 19, 2024 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Sep 21, 2021 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Sep 21, 2021 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Sep 21, 2021 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| May 18, 2021 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| May 19, 2020 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jul 31, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 4, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 19, 2015 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 3, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 3, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 11, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 23, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 22, 2015 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 22, 2015 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 22, 2015 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 22, 2015 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 22, 2015 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 21, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 20, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 20, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 15, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 15, 2014 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 15, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 24, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 24, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 24, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 20, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 28, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 28, 2014 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 28, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 28, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 10, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 31, 2014 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals for use in manufacturing pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals; Chemicals for use in the pharmaceutical industry; chemicals for use in the pharmaceutical industry, namely, intermediates for pharmaceuticals; intermediates being chemicals for use in industry, namely, chemicals for use in the manufacture of pharmaceuticals
Class 005
Pharmaceuticals, pharmaceutical compositions, and pharmaceutical preparations, used to treat cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection
Class 042
Scientific research and product development services in relation to pharmaceutical and medical products; scientific services, namely, product development in the field of pharmaceuticals; research, namely, scientific research and product development in the field of pharmaceuticals; industrial research in the field of pharmaceuticals; product design in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation; Testing of pharmaceuticals; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals; provision of scientific information in the fields of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; providing of scientific information regarding pharmaceuticals and medicines; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development
Class 044
Medical services, namely, providing medical information regarding pharmaceuticals; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; providing to others a collection of information, namely, providing medical information relating to the use of pharmaceuticals
Classification
International Classes
001
005
042
044